Multiple basal cell carcinomas after long-term exposure to hydrazine: Case report and review of the literature

Dermatology

Volumn 221, Issue 4, 2010, Pages 300-302

  Aigner, B A ^a   Darsow, U ^a   Grosber, M ^a   Ring, J ^a   Plotz S G ^b,c  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Krankenhaus Munich Harlaching   (Germany)

^c NONE   (Germany)

Author keywords

Basal cell carcinoma; Hydrazine; Occupational exposure

Indexed keywords

HYDRAZINE;

AGED; BASAL CELL CARCINOMA; CANCER DIAGNOSIS; CANCER RISK; CANCER SURGERY; CASE REPORT; DRUG EXPOSURE; ELECTRIC POWER PLANT; HUMAN; MALE; OCCUPATIONAL EXPOSURE; OCCUPATIONAL HAZARD; PRIORITY JOURNAL; REVIEW;

AGED; ARM; CARCINOMA, BASAL CELL; FACE; HUMANS; HYDRAZINES; MALE; OCCUPATIONAL DISEASES; OCCUPATIONAL EXPOSURE; SKIN NEOPLASMS;

EID: 78650987465     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321338     Document Type: Review

References (37)

1. ICPS 1991: international programme on chemical safety. Health and safety guide No 56. Hydrazine health and safety guide. http://www.inchem.org/documents/ hsg/ hsg/hsg056.htm.
2. International Agency for Research on Cancer: IARC monographs on the evaluation of carcinogenic risks to humans. Lyon, IARC, 1987, vol 71, suppl 7, pp 991-1013. http:// monographs.iarc.fr/ENG/Monographs/ vol71/mono71-43.pdf.
3. International Agency for Research on Cancer: Re-evaluation of some organic chemicals, hydrazine, and hydrogen peroxide. IARC monographs on the evaluation of carcinogenic risk of chemicals to humans. Lyon, IARC, 1999, vol 71. http://monographs.iarc. fr/ENG/Monographs/vol71/mono71.pdf.
4. Schmidt EW: Hydrazine and Its Derivates: Preparation, Properties and Applications. New York, Wiley & Sons, 1984.
5. Hazardous substances data base. National Library of Medicine. 2000. http://toxnet. nlm.nih.gov/cgi-bin/sis/htmlgen?HSDB.
6. Helmers S, Ruland RT, Jacob LN: Epitheloid sarcoma of the thumb associated with hydrazine fuel exposure: a case report. Military Med 2004; 169: 41-44.
7. The Merck Index, ed. 8. Rahway, Merck & Co, 1968.
8. Raphaelian LA: Hydrazine; in Kirk RE, Othmer DF (eds): Encyclopedia of Chemical Technology, ed 2. New York, Wiley & Sons, 1966, vol 11, pp 164-196.
9. Liu YY, Schmeltz I, Hoffmann D: Chemical studies on tobacco smoke: quantitative analysis of hydrazine in tobacco and cigarette smoke. Anal Chem 1974; 46: 885-889.
10. Evans DM: Two cases of hydrazine hydrate dermatitis without systemic intoxication. Br J Ind Med 1959; 16: 126-127.
11. Keilig W, Speer U: Occupational allergic contact dermatitis from hydrazine. Derm Beruf Umwelt 1983; 31: 25-27.
12. Van Ketel WG: Contact dermatitis from a hydrazine derivative in a stain remover: crosssensitization to apresoline and isoniazid. Acta Derm Venereol (Stockh) 1964; 44: 49-53.
13. Wrangsjo K, Martensson A: Hydrazine contact dermatitis from gold plating. Contact Dermatitis 1986; 15: 244-245.
14. Dilman VM, Anisimov VN: Potention of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenyletyhlbiguanide (phenformin). Cancer Lett 1979; 7: 357-361.
15. Gold J: Enhancement by hydrazine sulfate of antitumor effectiveness of cytoxan, mitomycin C, methotrexate and bleomycin, in walker 256 carcinosarcoma in rats. Oncology 1975; 31: 44-53.
16. Rogers AM, Back KC: Comparative mutagenicity of hydrazine and 3 methylated derivatives in L5178Y mouse lymphoma cells. Mutat Res 1981; 89: 321-328.
17. Bhide SV, D'Souza RA, Sawia MM, Ranadive KJ: Lung tumour incidence in mice treated with hydrazine sulfate. Int J Cancer 1976; 18: 530-535.
18. Severi L, Biancifiori C: Hepatic carcinogenesis in CBA/Cb/Se mice and CB/Se rats by isonicotinic acid hydrazide and hydrazine sulfate. J Natl Cancer Inst 1968; 41: 331-349.
19. Toth B: Lung tumor induction and inhibition of breast adenocarcinomas by hydrazine sulfate in mice. J Natl Cancer Inst 1969; 42: 469-475.
20. Biancifiori C, Gironelli-Santilli FE, Milia U, Severi L: Pulmonary tumours in rats induced by oral hydrazine sulphate. Nature 1966; 212: 414-415.
21. Shimizu H, Toth B: Effect of lifetime administration of 2-hydroxyethylhydrazine on tumorigenesis in hamsters and mice. J Natl Cancer Inst 1974; 52: 903-906.
22. Latendresse JR, Marit GB, Vernot EH, Haun CC, Flemming CD: Oncogenic potential of inhaled hydrazine in the nose of rats and hamsters after 1 or 10 1-hr exposures. Fundam Appl Toxicol 1995; 27: 33-48.
23. Morgenstern H, Ritz B: Effects of radiation and chemical exposures on cancer mortality among Rocketdyne workers: a review of three cohort studies. Occup Med 2001; 16: 219-237.
24. Ritz B, Morgenstern H, Froines J, Moncau J: Chemical exposures of rocket engine teststand personnel and cancer mortality in a cohort of aerospace workers. J Occup Environ Med 1999; 41: 903-910.
25. Ritz B, Zhao Y, Krishnadasan A, Kennedy N, Morgenstern H: Estimated effects of hydrazine exposure on cancer incidence and mortality in aerospace workers. Epidemiology 2006; 17: 154-161.
26. Back KC, Carter VL Jr, Thomas AA: Occupational hazards of missile operations with special regards to the hydrazine propellants. Aviat Space Environ Med 1978; 49: 591-598.
27. Keller WC: Toxicity assessment of hydrazine fuels. Aviat Space Environ Med 1988; 59: A100-A106.
28. Sotaniemi E, Hirvonen J, Isomaki H, Takkunen J, Kaila J: Hydrazine toxicity in the human: report of a fatal case. Ann Clin Res 1971; 3: 30-33.
29. Cammarano G, Crosignani P, Berrino F, Berra G: Cancer mortality among workers in a thermoelectric power plant. Scand J Work Environ Health 1984; 10: 259-261.
30. Dube M, Madarnas P, Rola-Pleszczynski M, Nigam VN: An animal model of Kaposi's sarcoma. I. Immune status of CD1 mice undergoing dimethyl hydrazine treatment to induce angiosarcomas and other malignancies. Anticancer Res 1992; 12: 105-112.
31. Madarnas P, Dube M, Rola-Pleszczynski M, Nigam VN: An animal model of Kaposi's sarcoma. II. Pathogenesis of dimethyl hydrazine induced angiosarcoma and colorectal cancer in three mouse strains. Anticancer Res 1992; 12: 113-117.
32. Albert DM, Puliafito CA: Chorioidal melanoma: possible exposure to industrial toxins. New Engl J Med 1977; 296: 634-635.
33. Choudhary G, Hansen H: Human health perspective on environmental exposure to hydrazines: a review. Chemosphere 1998; 37: 801-843.
34. Bajdik CD, Gallagher RP, Astrakianakis G, Hill GB, Fincham S, McLean DI: Non-solar ultraviolet radiation and the risk of basal and squamous cell skin cancer. Br J Cancer 1996; 73: 1612-1614.
35. Dixon AJ, Dixon BF: Ultraviolet radiation from welding and possible risk of skin and ocular malignancy. Med J Aust 2004; 181: 155-157.
36. Currie CLA, Monk BE: Welding and nonmelanoma skin cancer. Clin Exp Dermatol 2000; 25: 28-29.
37. Emmett EA, Buncher CR, Suskind RB, Rowe KW Jr: Skin and eye diseases among arc welders and those exposed to welding operations. J Occup Med 1981; 23: 85-90.